Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aparajita Khatri

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Expert Opinion on Investigational Drugs|July 25, 2006
Novel gene-directed enzyme prodrug therapies against prostate cancerPamela J Russell, Aparajita Khatri
Discovery Medicine|March 9, 2007
Targeted, gene-directed enzyme prodrug therapies to tackle diversity and aggression of late stage prostate cancerAparajita Khatri, Pamela J Russell
Journal of Immunological Methods|August 11, 2007
Murine CTLL-2 cells respond to mIL12: prospects for developing an alternative bioassay for measurement of murine cytokines IL12 and IL18Aparajita Khatri, Yasmin Husaini, Pamela J Russell
Cancer Metastasis Reviews|February 10, 2010
Modeling prostate cancer: a perspective on transgenic mouse modelsVarinder Jeet, Pamela J Russell, Aparajita Khatri
Discovery Medicine|December 21, 2007
Magnetic nanoparticles: prospects in cancer imaging and therapyMonica Tang, Pamela J Russell, Aparajita Khatri
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2009
Cytosine deaminase-uracil phosphoribosyltransferase and interleukin (IL)-12 and IL-18: a multimodal anticancer interface marked by specific modulation in serum cytokinesAparajita Khatri, Yasmin Husaini, Kim Ow, et al.
BMC Cancer|August 25, 2011
Purine Nucleoside Phosphorylase mediated molecular chemotherapy and conventional chemotherapy: a tangible union against chemoresistant cancerPreetinder P Singh, Swapna Joshi, Pamela J Russell, et al.
The Prostate|February 6, 2008
Broadening of transgenic adenocarcinoma of the mouse prostate (TRAMP) model to represent late stage androgen depletion independent cancerVarinder Jeet, Kim Ow, Eboney Doherty, et al.
Stem Cells (Dayton, Ohio)|July 15, 2010
Concise review: Nanoparticles and cellular carriers-allies in cancer imaging and cellular gene therapy?Catherine Tang, Pamela J Russell, Rosetta Martiniello-Wilks, et al.
Pharmaceutics|March 29, 2023
Enhanced Skin Penetration of Cannabidiol Using Organosilane Particles as Transdermal Delivery VehiclesZahra Khabir, Connie Partalis, Jimit Vijay Panchal, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Expert Opinion on Investigational Drugs|July 25, 2006
Novel gene-directed enzyme prodrug therapies against prostate cancerPamela J Russell, Aparajita Khatri
Discovery Medicine|March 9, 2007
Targeted, gene-directed enzyme prodrug therapies to tackle diversity and aggression of late stage prostate cancerAparajita Khatri, Pamela J Russell
Journal of Immunological Methods|August 11, 2007
Murine CTLL-2 cells respond to mIL12: prospects for developing an alternative bioassay for measurement of murine cytokines IL12 and IL18Aparajita Khatri, Yasmin Husaini, Pamela J Russell
Cancer Metastasis Reviews|February 10, 2010
Modeling prostate cancer: a perspective on transgenic mouse modelsVarinder Jeet, Pamela J Russell, Aparajita Khatri
Discovery Medicine|December 21, 2007
Magnetic nanoparticles: prospects in cancer imaging and therapyMonica Tang, Pamela J Russell, Aparajita Khatri
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2009
Cytosine deaminase-uracil phosphoribosyltransferase and interleukin (IL)-12 and IL-18: a multimodal anticancer interface marked by specific modulation in serum cytokinesAparajita Khatri, Yasmin Husaini, Kim Ow, et al.
BMC Cancer|August 25, 2011
Purine Nucleoside Phosphorylase mediated molecular chemotherapy and conventional chemotherapy: a tangible union against chemoresistant cancerPreetinder P Singh, Swapna Joshi, Pamela J Russell, et al.
The Prostate|February 6, 2008
Broadening of transgenic adenocarcinoma of the mouse prostate (TRAMP) model to represent late stage androgen depletion independent cancerVarinder Jeet, Kim Ow, Eboney Doherty, et al.
Stem Cells (Dayton, Ohio)|July 15, 2010
Concise review: Nanoparticles and cellular carriers-allies in cancer imaging and cellular gene therapy?Catherine Tang, Pamela J Russell, Rosetta Martiniello-Wilks, et al.
Pharmaceutics|March 29, 2023
Enhanced Skin Penetration of Cannabidiol Using Organosilane Particles as Transdermal Delivery VehiclesZahra Khabir, Connie Partalis, Jimit Vijay Panchal, et al.
Pageof 2